© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
May 29, 2021
An assessment of the frontline agents show similarities infection cure and recurrence rates at 30 days.
May 20, 2021
A meta-analysis suggest the 2 first-line C diff therapies provide similar outcomes, yet differ in recurrent infection risk.
May 18, 2021
A study shows countries with the highest income levels had greater vaccine protection against rotavirus gastroenteritis (RVGE).
April 23, 2021
Experts discuss the bacteria’s transmission in the community setting, how to reduce disease and economic burdens, and ways to improve quality of life for patients.
April 14, 2021
January 08, 2021
Therapies in the pipeline to treat C. difficile and closing thoughts on what is most exciting, in regards to better prevention and management of the condition, moving forward.
Current barriers associated with the use of fecal microbiota transplantation for C. difficile infections.
Healthcare experts comment on current data associated with emerging microbiota therapies that are currently under study for the treatment of C. difficile infections.
Panelists discuss the use of fecal microbiota transplantation as treatment for eligible patients with C. difficile.
Current gaps in the prevention/treatment of C. difficile infections, as highlighted by leading healthcare professionals.